Trials / Conditions / Palmoplantaris Pustulosis
Palmoplantaris Pustulosis
4 registered clinical trials studyying Palmoplantaris Pustulosis.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | A Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Japanese Subjects With Palmoplantar Pu NCT04057937 | Amgen | Phase 2 |
| Completed | A Study of the Efficacy, Safety and Tolerability of CNTO 1959, a Human Anti-IL 23 Monoclonal Antibody in Parti NCT01845987 | Janssen Pharmaceutical K.K. | Phase 2 |
| Completed | A Placebo-Controlled Double-Blind Study on the Safety and Efficacy of Etanercept in Palmoplantar Pustulosis NCT00353119 | Innovaderm Research Inc. | Phase 3 |
| Completed | Study to Evaluate the Efficacy of Alefacept to Treat Palmar Plantar Pustulosis NCT00301002 | The Guenther Dermatology Research Centre | Phase 2 |